ATP Life Science Ventures, L.P. - Jun 28, 2021 Form 4 Insider Report for Akero Therapeutics, Inc. (AKRO)

Role: 10%+ Owner
Signature: /s/ Seth L. Harrison, for ATP Life Science Ventures, L.P., By: Seth L. Harrison, as director of ATP III GP, Ltd., its general partner
Stock symbol: AKRO
Transactions as of: Jun 28, 2021
Transactions value $: $0
Form type: 4
Date filed: 6/30/2021, 04:31 PM

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AKRO	Common Stock	Other		-5.83M	-100%		0	Jun 28, 2021	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

ATP Life Science Ventures, L.P. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	The shares were distributed in a pro rata distribution to the limited partners of ATP Life Science Ventures, L.P. ("ATP," and formerly known as Apple Tree Partners IV, L.P.).
F2	The shares were directly held by ATP. ATP III GP, Ltd. ("ATP GP") is the sole general partner of ATP. Seth L. Harrison is a director on the Issuer's board of directors and is the sole director of ATP GP. ATP GP and Dr. Harrison disclaim beneficial ownership of the reported shares, except to the extent of any pecuniary interest therein.